Knobbe Martens Olson & Bear LLP

Partner

Dr. Dave Schmidt’s practice involves global strategic patent procurement, patent portfolio management, intellectual property due diligence, licensing, and general counseling on infringement, including pre-litigation strategy. Dave currently represents clients in a variety of technologies, with an emphasis on medical devices, pharmaceuticals, biotechnology, and materials. In the medical field, Dave has extensive experience in wound care, endoscopy, drug delivery, cardiovascular, surgical tools, and orthopedic technologies.

Dave has an extensive technical background, including a Ph.D. in biomedical engineering and M.S. degrees in both biomedical engineering and pharmaceutical sciences. Dave’s Ph.D thesis focused on host interactions with biomaterials in wound healing, including drug delivery interactions.

Dave has guided the IP strategies for investments and acquisitions valued in excess of several billion dollars, including Acera Surgical (acquired by Solventum), iRhythm Technologies (initial public offering), Tenex Health (acquired by Trice Medical), Seg-Way (acquired by Trice Medical), AVITA Medical (debt financing with OrbiMed), and Paragonix Technologies (acquisition by Getinge).

Dave has been recognized in the IAM Strategy 300 as among the world’s leading IP strategists. Dave has also been recognized in the Best Lawyers guide and the Legal 500 for patent prosecution.